Peer Review History

Original SubmissionFebruary 15, 2025
Decision Letter - Yogesh Kumar Jain, Editor

Dear Dr. Zyambo,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

The manuscript has received an overall positive feedback from the reviewers. However, there seems some major recommendations on the clarity of the messages conveyed. You are requested to kindly revise as per the comments mentioned below. Please submit the versions with tracked changes turned on, along with an in-line reply to individual reviewers comments so that the changes may easily be tracked during the re-review process.

==============================

Please submit your revised manuscript by May 23 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Yogesh Kumar Jain, MPH

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

3. Thank you for stating the following financial disclosure: 

Global Fund

Please state what role the funders took in the study.  If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

4. In the online submission form, you indicated that the data is available if requested from the university of Zambia and the Ministry of Health in Zambia

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes

**********

Reviewer #1: Thank you for the opportunity to review this manuscript on tobacco use among people living with HIV (PLWH) in Zambia. The study addresses an important research gap regarding tobacco consumption patterns and associated factors in this population based on a nationwide cross-sectional survey.

Strengths

The study addresses a significant research gap in the region by examining tobacco use patterns among PLWH in Zambia

The nationwide cross-sectional design provides valuable population-level insights

The findings may have important implications for local health policy development

Major Concerns

Formatting and Clarity Issues

Multiple instances of formatting errors, punctuation mistakes, and incorrect abbreviation usage require thorough revision

Several ambiguous statements need clarification, particularly in the abstract. For example, it is unclear whether the gender-specific percentages (21.9% men and 3.7% women) are subsets of the 9.7% current tobacco smokers or represent different calculations

Statistical Methodology

The manuscript fails to specify how missing data for dependent variables was handled (full case analysis vs. interpolation)

There is no mention of strategies to address multiple comparisons when assessing associations of multiple factors with two outcome variables, potentially increasing Type I error risk

No evidence of multicollinearity assessment, which is crucial for ensuring model stability and accuracy

The absence of common goodness-of-fit indicators (e.g., pseudo-R², Hosmer-Lemeshow test) limits evaluation of model reliability and applicability

Contextual Integration

The discussion would benefit from better integration with the current state of Zambia's healthcare system

More consideration of how findings relate to local health infrastructure and policy would enhance practical relevance

Recommendations

Conduct a thorough review of the manuscript for grammatical errors, formatting inconsistencies, and unclear abbreviations

Clarify ambiguous statistical presentations, especially in the abstract

Provide complete information on statistical methodology, including missing data handling, multiple comparison adjustments, multicollinearity testing, and goodness-of-fit measures

Strengthen the discussion by better contextualizing findings within Zambia's healthcare landscape and considering implementation implications

For more specific comments, please refer to the annotations in the document.

Reviewer #2: I would like to congratulate the authors on this fine piece of work, exploring an important public health issue in SSA. I would recommend a major revision of the manuscript before acceptance.

In line 120, the authors mentioned that “Because the main focus of the parent study was NCD’s among PLWH, all pregnant women and breastfeeding mothers were excluded from the study”. Please kindly explain the rationale of including age group of 18-29 years old.

Sampling yielded a result of 67.2% females and 32.8% males PLWH (line 182). Is this generally representative of the statistics of PLWH living in the community among SSA? If this is not so, please explain why you think the study results deviate from statistics in the community. Please do input these thoughts under discussion.

In line 267, the authors mentioned that the unexpected finding was due to under reporting due to social desirability bias which could be the case. What is another possible explanation for this difference?

In lines 355-363, the authors should consider rephrasing the sentences, paying attention to sentence structuring and how future direction should be undertaken with respect to the study findings. Do take note that the associations are not causal as the authors have rightly pointed out. Henceforth, one should be careful in mentioning the intervention and associating them with subsequent reduction in tobacco use. For example, does improving financial means truly reduce reliance on smokeless tobacco use or is education an intermediary between financial situation and tobacco use?

Reviewer #3: -The introduction mentions that "Zambia currently lacks a structured smoking cessation policy for individuals attending routine HIV clinics". It might be strengthened by briefly discussing the potential impact of such a policy and how the study findings could inform its development.

-pregnant women and breastfeeding mothers are excluded from your study. While the reasoning is provided, it would be useful to briefly discuss the potential implications of this exclusion on the generalizability of the findings.

-Could you elaborate on the strategies that could be used to minimize social desirability bias in future research on tobacco use among PLWH?

-What specific clinical and public health interventions do you recommend based on your findings, and how could these be implemented in the Zambian context?

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes:  Adane Mekonnen Gebrewold

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Attachments
Attachment
Submitted filename: PONE-D-25-05511_reviewer.pdf
Attachment
Submitted filename: Review PLOS_2.docx
Revision 1

Dear PLOS ONE: Editors and Staff,

On behalf of all authors of “Tobacco smoking and Smokeless tobacco use among People Living with HIV in Zambia Findings from a 2023 National NCD/HIV Survey” we sincerely thank you for the opportunity to resubmit our manuscript for consideration. We would also like to thank the reviewers whose thorough evaluation of our work has given us the opportunity to make substantive improvements. Below is a point-by-point response to the concerns and comments of the reviewers. Whenever possible we have endeavored to integrate the recommendations from the initial review.

On the funding, we add this statement “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Again, we are appreciative of this opportunity to resubmit our work to PLOS ONE. With the help of the academic editor and reviewers, we believe we are resubmitting an improved text.

Sincerely,

Cosmas Zyambo

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response: This has been done

2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

Response: This has been done

3. Thank you for stating the following financial disclosure:

Global Fund

Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.""

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

Response: This has been done

4. In the online submission form, you indicated that the data is available if requested from the university of Zambia and the Ministry of Health in Zambia

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval.

Response: This paper is a series of papers that are still being written. Analysis is currently on going for other papers. All the data after the analysis will be submitted to the National health Ethics authority website provided https://www.nhra.org.zm/. For further details regarding the dataset, kindly reach out to the Principal Investigator, Prof. Wilbroad Mutale. wmutale@yahoo.com

Reviewer #1:

Reviewer #1: Thank you for the opportunity to review this manuscript on tobacco use among people living with HIV (PLWH) in Zambia. The study addresses an important research gap regarding tobacco consumption patterns and associated factors in this population based on a nationwide cross-sectional survey.

Strengths

The study addresses a significant research gap in the region by examining tobacco use patterns among PLWH in Zambia. The nationwide cross-sectional design provides valuable population-level insights. The findings may have important implications for local health policy development

Response: We thank you for these comments on the significance of our manuscript and for the recommendations. We have endeavored to address the concerns which have resulted in substantive improvements to the manuscript, as detailed below:

Major Concerns

Formatting and Clarity Issues

Multiple instances of formatting errors, punctuation mistakes, and incorrect abbreviation usage require thorough revision

Several ambiguous statements need clarification, particularly in the abstract. For example, it is unclear whether the gender-specific percentages (21.9% men and 3.7% women) are subsets of the 9.7% current tobacco smokers or represent different calculations

Response: The abstract has been modified to enhance clarity and readability. The statement “9.7% were current tobacco smokers (21.9% men, 3.7% women) ….” entails that of the 9,7% who are current smokers, 21.7% are males and 3.7% are females. They are enclosed in brackets

Statistical Methodology

The manuscript fails to specify how missing data for dependent variables was handled (full case analysis vs. interpolation).

Response:

Thank you for this important observation. We confirm that a complete case analysis was conducted on 1,356 observations. The reduction in sample size primarily resulted from a prerequisite question on whether a study participant had ever been tested for diabetes. Approximately more than half of the participants responded "No," and as such, the key variable indicating whether they had been told they had raised blood sugar or diabetes, which was included in the model, only had responses from those who answered "Yes" to being tested.

Furthermore, likelihood ratio tests used to determine the best-fitting model require consistent observations across all models being compared. This necessitated the exclusion of records with missing data on any of the model variables. Therefore, only complete cases were retained, and no imputation or interpolation methods were applied.

As shown in the screenshot below, complete observations were identified using a binary variable complete, where only observations with complete == 1 were retained for the multivariable analysis. This ensured that all included cases had non-missing values across all variables used in the models.

There is no mention of strategies to address multiple comparisons when assessing associations of multiple factors with two outcome variables, potentially increasing Type I error risk

Response:

We analysed the two outcome variables separately and did not apply formal adjustments for multiple comparisons.

No evidence of multicollinearity assessment, which is crucial for ensuring model stability and accuracy

Response:

We did conduct a multicollinearity assessment for all variables included in the model. As shown in the collinearity results image below, Spearman’s rho estimates indicate that none of the variables were strongly correlated.

The absence of common goodness-of-fit indicators (e.g., pseudo-R², Hosmer-Lemeshow test) limits evaluation of model reliability and applicability

Response: We did conduct the McFadden’s pseudo-R² value of 0.1921, which indicates a moderate model fit.

Contextual Integration

The discussion would benefit from better integration with the current state of Zambia's healthcare system

More consideration of how findings relate to local health infrastructure and policy would enhance practical relevance

Response: This has been added in the discussion as highlighted yellow in the manuscript “Zambia faces pressing public health challenges among PLWH, with tobacco use intensifying health risks amid the country’s dual burden of infectious and non-communicable diseases. Despite significant progress in HIV management through widespread ART access, tobacco use remains an often-overlooked factor that threatens to undermine this advancement. The strong association between tobacco use and non-adherence to ART underscores the urgency of integrating tobacco cessation interventions within HIV care settings. Given Zambia’s existing healthcare infrastructure, primary care facilities and ART clinics present a strategic opportunity to implement comprehensive tobacco cessation programs, ensuring a more holistic approach to patient care”

Response: The implementation implication of the study has been added in the conclusion as highlighted yellow in the manuscript” our findings underscore the importance of embedding tobacco cessation strategies within Zambia's existing HIV care framework. Healthcare facilities offering ART services should integrate routine screening for tobacco use and provide counseling or referrals to cessation support programs. Strengthening collaborations between public health authorities and community organizations could ensure broader outreach, particularly to low-income groups more vulnerable to SLT use. Policy-wise, reinforcing tobacco control regulations and enhancing public awareness campaigns would be instrumental in reducing tobacco use among PLWH. Furthermore, addressing alcohol consumption—given its strong association with both smoking and SLT use—through targeted behavioral interventions in HIV clinics could yield positive outcomes. By contextualizing the findings within Zambia's healthcare challenges and aligning proposed interventions with existing resources, our study contributes to a more actionable framework for reducing tobacco use among PLWH in Zambia”

Recommendations

Conduct a thorough review of the manuscript for grammatical errors, formatting inconsistencies, and unclear abbreviations

Clarify ambiguous statistical presentations, especially in the abstract

Provide complete information on statistical methodology, including missing data handling, multiple comparison adjustments, multicollinearity testing, and goodness-of-fit measures

Strengthen the discussion by better contextualizing findings within Zambia's healthcare landscape and considering implementation implications

Response: Thank you for the recommendation, these have been addressed as above and as highlighted yellow in the manuscript

Reviewer #2: I would like to congratulate the authors on this fine piece of work, exploring an important public health issue in SSA. I would recommend a major revision of the manuscript before acceptance.

Response: We thank you for these comments on the impotence of our manuscript and for the suggestions. We have endeavored to address the concerns which have resulted in substantive improvements to the manuscript, as detailed below:

In line 120, the authors mentioned that “Because the main focus of the parent study was NCD’s among PLWH, all pregnant women and breastfeeding mothers were excluded from the study”. Please kindly explain the rationale of including age group of 18-29 years old.

Response: The statement on the reason why the 18-29 years group was added has been added in the manuscript as highlighted in yellow. “Inclusion of the age group of 18–29 years in this study is crucial because young adults are at a pivotal life stage marked by transitions in education, employment, and social environments, all of which influence health behaviors, including tobacco use. Peer pressure, growing independence, and exposure to various stressors make them particularly vulnerable to initiating and sustaining tobacco use. From a healthcare perspective, understanding tobacco use patterns in this group enables early intervention, helping to mitigate long-term health risks, especially among PLWH, where tobacco exacerbates complications. Insights from this analysis can inform youth-focused prevention strategies, awareness campaigns, and policy measures designed to curb tobacco use before it becomes deeply ingrained.”

Sampling yielded a result of 67.2% females and 32.8% males PLWH (line 182). Is this generally representative of the statistics of PLWH living in the community among SSA? If this is not so, please explain why you think the study results deviate from statistics in the community. Please do input these thoughts under discussion.

Response: In Sub-Saharan Africa (SSA), women generally make up a higher proportion of people living with HIV (PLWH) compared to men. This is largely due to biological, social, and economic factors that increase women's vulnerability to HIV infection. While exact percentages vary by country, most studies indicate that women account for a significant majority of PLWH in the region. Our study’s finding of 67.2% females and 32.8% males aligns with broader trends observed in SSA, where women often represent over 60% of the HIV-positive population. Our study does not depart from literature in the SSA.

In line 267, the authors mentioned that the unexpected finding was due to under reporting due to social desirability bias which could be the case. What is another possible explanation for this difference?

Response: The other possible reason has been added in the manuscript as highlighted in yellow: “…. however, the prevalence of tobacco use among PLWH in our study did not differ from that of the general population, which is unexpected. One possible explanation is that our study may have captured a subset of PLWH who are more health-conscious or adherent to healthcare recommendations, resulting in a prevalence similar to that of the general population. The most plausible reason, however, could be underreporting due to social desirability bias. PLWH who actively seek healthcare may be more inclined to underreport tobacco use due to stigma or concerns about being advised to quit, potentially leading to a lower reported prevalence than actual usage rates”

In lines 355-363, the authors should consider rephrasing the sentences, paying attention to sentence structuring and how future direction should be undertaken with respect to the study findings. Do take note that the associations are not causal as the authors have rightly pointed out. Henceforth, one should be careful in mentioning the intervention and associating them with subsequent reduction in tobacco use. For example, does improving financial means truly reduce reliance on smokeless tobacco use or is education an intermediary between financial situation and tobacco use?

Response: we have restructured and modified this part for clarity and readability. The addition has been highlighted yellow in the manuscript. “….our findings underscore the importance of embedding tobacco cessation strategies within Zambia's existing HIV care framework. Healthcare facilities offering ART services should integrate routine screening for tobacco use and provide counseling or referrals to cessation support programs. Strengthening collaborations between public health authorities and community organizations could ensure broader outreach, particularly to low-income groups more vulnerable to SLT use. Policy-wise, reinforcing tobacco control regulations and enhancing public awareness campaigns would be instrumental in reducing tobacco use among PLWH. Furthermore, addressing alcohol consumption—given its strong association with both smoking and SLT use—through targeted behavioral interventions in HIV clinics could yield positive outcomes. By contextualizing the findings within Zambia's healthcare challenges and aligning proposed interventions with existing resources, our study contributes to a more actionable framework for reducing tobacco use among PLWH in Zambia”

Reviewer #3: -The introduction mentions that "Zambia currently lacks a structured smoking cessation policy for individuals attending routine HIV clinics". It might be strengthened by briefly discussing the potential impact of such a policy and how the study findings could inform its development.

Response: This sentence has been added (as highlighted in yellow) to strengthen the introduction on the cessation policy and how the study might add to the cessation policy formulation.” A structured smoking cessation policy could significantly

Decision Letter - Yogesh Kumar Jain, Editor

Tobacco smoking and Smokeless tobacco use among People Living with HIV in Zambia Findings from a 2023 National NCD/HIV Survey

PONE-D-25-05511R1

Dear Dr. Zyambo,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Yogesh Kumar Jain, MPH

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

**********

Reviewer #1: I am of the opinion that the quality of the paper has been significantly improved after this revision and there are no longer any significant revisions. The paper is innovative to a certain extent, the research content is abundant, the methodology is scientific and reasonable, the results are reliable, and it has certain reference value for the research in related fields, so it is suggested that it can be considered for acceptance for publication. However, it is hoped that the authors will again scrutinize the paper for typos, improper use of punctuation and other minor problems during the subsequent proofreading process to ensure the perfect presentation of the paper.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

**********

Formally Accepted
Acceptance Letter - Yogesh Kumar Jain, Editor

PONE-D-25-05511R1

PLOS ONE

Dear Dr. Zyambo,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Yogesh Kumar Jain

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .